Flywheel’s platform helps automate the ingestion, classification and analysis of medical images collected from radiology scans and digital pathology programs as well as data from electronic health…
With its proposed SPAC deal only days away from shareholder approval, Pear Therapeutics is already plotting out its future as a publicly traded company.
Connect Biopharma connected to the investor community Friday, but not in the way it wanted, as its stock sunk 57% by end of trading on what it touted as positive data for its eczema asset.
Xencor has finally found a buyer for its autoimmune disease bispecific antibody obexelimab. Almost three years after deciding to partner the drug in the wake of a failed phase 2, Xencor has offloaded…
Affiliates of Bain Capital and Hellman & Friedman struck a deal to buy the health IT company from its current private equity owners. Veritas Capital and an affiliate of activist investor Elliott…
Recent advances in technology have created an opportunity for traditional providers to overcome these hurdles and deliver virtual PT in a way that is convenient for both patients and frontline…
Neurocrine Biosciences and Sosei Heptares, no strangers to major research pacts, are joining forces for a range of early- to midstage neuro assets.
Justin Norden Justin Norden, MD, is a partner at GSR Ventures, where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI, which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP-based platform for biopharma decision-making), …
Admittedly, Medicaid is not the market most entrepreneurs think about when starting a company for the first time, which is why it is even more critical for VCs to support these initiatives.
Nephrology products company Vifor Pharma is shelling out about $252 million combined up front to acquire Sanifit Therapeutics and Inositec, developers of drugs for a blood vessel complication…
